Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Effective cash flow management is key to financial success. Discover tips to enhance your zero-based budgeting strategy.
25,593 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
A record M&A surge, pegged at roughly $4 trillion for 2026, is shaping the market. Wall Street is weighing whether a ...
U.S. markets wobbled as Opendoor dropped on margin concerns while housing demand hints kept some optimism alive. This...
A new player in the chip foundry race is signaling aggressive pricing. If a potential rival wants undercut, investors...
Quantum computing is still in its early innings, and Rigetti Computing sits at a pivotal crossroads. This article bre...
The NEOS Nasdaq-100 High Income ETF (QQQI) currently yields almost 14%, drawing income seekers. But can this strategy...
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Futures point to a weaker start as AI fears push U.S. stocks being battered lower, even as international markets rall...
A New York federal court ruled that firms that paid emergency tariffs later deemed unlawful may seek refunds. The dec...
Quantum stocks jump on optimism about next-gen tech, yet analysts caution that lofty valuations outpace current earni...
Imagine a single, low-cost index fund doing the heavy lifting for decades. This guide shows how to turn that idea int...
Meta is weighing a large primary equity offering to fund an aggressive AI buildout as costs rise. Analysts warn dilut...